Omega Flex, Inc. 2022 Form 10-K Summary
Business context and reporting period
Omega Flex manufactures and sells flexible metal hose, fittings, and accessories through distributors, wholesalers, independent sales organizations, OEMs, and direct channels. Core applications include residential and commercial fuel-gas piping, double-containment fuel piping, medical-gas tubing, and industrial fluid and gas handling. The company operates as one segment, with manufacturing in Exton, Pennsylvania; Houston, Texas; and Banbury, United Kingdom.
This filing covers the fiscal year ended December 31, 2022, and compares results primarily with fiscal 2021. It is an annual Form 10-K rather than a quarterly filing.
Financial performance and liquidity
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Net sales | $125.5 million | $130.0 million | Down 3.5% |
| Gross profit | $78.3 million | $81.5 million | Down 4.0% |
| Gross margin | 62.4% | 62.7% | Down 30 basis points |
| Operating profit | $31.0 million | $35.1 million | Down 11.5% |
| Operating margin | 24.7% | 27.0% | Down 230 basis points |
| Net income | $23.7 million | $26.3 million | Down 9.9% |
| Net income attributable to Omega Flex | $23.6 million | $26.2 million | Down 9.8% |
| Basic and diluted EPS | $2.34 | $2.60 | Down 10.0% |
| Cash flow from operations | $15.2 million | $25.1 million | Down $9.9 million |
| Capital expenditures | $0.9 million | $1.0 million | Down $0.03 million |
| Cash and cash equivalents | $37.7 million | $32.9 million | Up 14.6% |
Sales declined primarily because of lower unit volume, while pricing actions largely offset higher material costs and preserved gross margins. Selling expense increased 7.4% to $21.9 million, principally because travel, marketing, staffing, and commissions resumed or increased from pandemic-affected 2021 levels. General and administrative expense decreased 3.8% to $20.6 million, primarily because of lower incentive compensation and stock-based compensation, partly offset by higher legal and product-liability costs.
The company had no borrowings under its $15.0 million revolving credit facility at December 31, 2022, and was in compliance with its debt covenants. The facility was extended to June 1, 2023. Management stated that cash and borrowing capacity should be sufficient to meet anticipated needs for at least the next twelve months.
Dividends paid totaled $9.5 million in 2022, compared with $14.9 million in 2021. The regular quarterly dividend increased from $0.30 per share for the first quarter of 2022 to $0.32 per share for each of the remaining three quarters. Dividends declared per share totaled $1.26 for 2022.
Material changes versus the prior comparable period
- Net sales decreased $4.5 million, primarily due to lower volume; the company reported a modest decline in residential housing starts during 2022.
- Gross margin remained broadly stable despite significantly higher nickel and other material costs, supported by pricing actions.
- Operating margin contracted as selling expenses rose while revenue declined.
- Operating cash flow fell substantially, reflecting increased inventory purchases, lower accrued compensation and sales incentives, and higher other asset balances.
- Inventory increased 14.1% to $17.8 million to support supply-chain requirements and higher costs. Inventories expected to be used beyond twelve months, primarily for corrugated medical tubing, totaled $4.3 million and were classified as other long-term assets.
- Accounts receivable declined 15.6% to $17.5 million, which management attributed mainly to collection timing.
- Other liabilities increased 54.8% to $7.5 million, primarily because of accruals for legal and product-liability matters.
- Product-liability reserves increased to $3.8 million from $0.3 million at year-end 2021.
Guidance, outlook, commentary, risks, and unusual items
The filing does not provide quantitative revenue, earnings, or margin guidance. Management expects demand to remain affected by construction activity, interest rates, seasonal weather patterns, commodity costs, and supply-chain conditions. The company intends to continue developing flexible metal products and expanding applications, including MediTrac medical tubing and other industrial and double-containment products.
- Customer concentration: One distributor represented approximately 12% to 13% of sales in each year from 2020 through 2022 and 7% to 19% of accounts receivable during the last two years.
- Product concentration: Most sales and profits depend on TracPipe and CounterStrike flexible gas-piping systems, fittings, and accessories.
- Commodity and supply risk: Stainless steel, nickel, copper, polyethylene, and fittings are important inputs. The company relies on one to three sources for many key materials and components.
- Construction and energy-transition risk: Higher interest rates or weaker residential construction could reduce demand. Policies restricting natural-gas or propane use could materially reduce demand for the company’s principal products.
- Legal contingencies: The company faces recurring product-liability claims, primarily involving alleged lightning damage to flexible gas piping. Aggregate maximum exposure for current open claims was estimated not to exceed $7.4 million, while the recorded reserve was $3.8 million. Management cannot estimate the ultimate liability.
- International and operational risks: Brexit-related logistics, foreign currency movements, geopolitical events, tariffs, manufacturing disruptions, cybersecurity incidents, and COVID-19 developments could affect results.
- Unusual accounting and compensation items: Phantom-stock liabilities totaled $1.3 million at year-end, with $0.7 million expected to be paid within twelve months. The plan was amended for grants beginning January 1, 2023.
- Audit and controls: RSM US LLP issued unqualified opinions on the financial statements and internal control over financial reporting. Product-liability claims were identified as the critical audit matter.
Important facts for investors to verify
- Whether lower unit volumes and weaker construction activity continue into 2023.
- Whether pricing actions can continue to offset stainless steel, nickel, copper, polyethylene, and other input-cost inflation without impairing demand.
- The status, defense costs, insurance coverage, and ultimate exposure associated with the open product-liability claims.
- The sustainability of operating cash flow after inventory purchases and dividend payments.
- The renewal or replacement terms of the $15.0 million revolving credit facility and any transition from LIBOR to another reference rate.
- Customer and distributor concentration, particularly the company’s largest distribution customer.
- Adoption, growth, and profitability of MediTrac and other newer product lines relative to the core fuel-gas business.
- Potential effects of regulations or market shifts away from natural gas and propane.